Retrieve available abstracts of 6 articles: HTML format
Single Articles
April 2025
MOON AM, Lupu GV, Green EW, Deutsch-Link S, et al Rural-urban disparities in hepatocellular carcinoma deaths are driven by
hepatitis C-related HCC.
Am J Gastroenterol. 2025 Apr 11. doi: 10.14309/ajg.0000000000003487. PubMedAbstract available
February 2024
BUI H, Kumar NG, Singal AG, Boparai J, et al Implementation of a hepatocellular carcinoma surveillance program in a
community-based integrated health system in patients with hepatitis C cirrhosis.
Am J Gastroenterol. 2024 Feb 9. doi: 10.14309/ajg.0000000000002704. PubMedAbstract available
December 2023
HU TH, Luh DL, Tsao YY, Lin TY, et al Utilizing the Diabetes Care System for A County-wide Hepatitis C Elimination: An
Integrated Community-based Shared Care Model in Taiwan.
Am J Gastroenterol. 2023 Dec 12. doi: 10.14309/ajg.0000000000002624. PubMedAbstract available
BARRITT AS 4TH, Barnhart H, Gu J, Dellinger A, et al When Is Suspected Drug-Induced Liver Injury (DILI) Not DILI? An Analysis of
Unlikely Cases From the Drug-Induced Liver Injury Network.
Am J Gastroenterol. 2023;118:2301-2304. PubMedAbstract available
July 2023
BARNHILL MS, Vargas HE Immune-Checkpoint Inhibitors in the Hepatitis C-Infected Patient: To Use or Not
to Use?
Am J Gastroenterol. 2023 Jul 10. doi: 10.14309/ajg.0000000000002352. PubMed
June 2023
YIBIRIN M, Mustafayev K, Hosry J, Pundhir P, et al Immune Checkpoint Inhibitors Suppress Hepatitis C Virus Replication in Infected
Patients with Solid Tumors.
Am J Gastroenterol. 2023 Jun 13. doi: 10.14309/ajg.0000000000002361. PubMedAbstract available